Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Combination of viral and bacterial antigens
Reexamination Certificate
2007-11-20
2010-06-15
Zeman, Robert A (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Combination of viral and bacterial antigens
C424S184100, C424S185100, C424S190100, C424S203100
Reexamination Certificate
active
07736658
ABSTRACT:
This invention relates to vaccines and methods for protecting dogs against disease caused byBordetella bronchiseptica. This invention also relates to combination vaccines and methods for protecting dogs against disease or disorder caused by canine pathogens, for example, infectious tracheobronchitis caused byBordetella bronchiseptica, canine distemper caused by canine distemper (CD) virus, infectious canine hepatitis (ICH) caused by canine adenovirus type 1 (CAV-1), respiratory disease caused by canine adenovirus type 2 (CAV-2), canine parainfluenza caused by canine parainfluenza (CPI) virus, enteritis caused by canine coronavirus (CCV) and canine parvovirus (CPV), and leptospirosis caused byLeptospira Bratislava, Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiaeorLeptospira pomona. The vaccines of the present invention include aBordetella bronchisepticap68 antigen.
REFERENCES:
patent: 3950512 (1976-04-01), Emery et al.
patent: 4567042 (1986-01-01), Acree et al.
patent: 4567043 (1986-01-01), Acree et al.
patent: 4810494 (1989-03-01), Welsh
patent: 4824785 (1989-04-01), Acree et al.
patent: 465204 (1992-01-01), None
patent: 0 535 740 (1993-04-01), None
patent: 1016416 (2000-07-01), None
patent: 1 023 904 (2000-08-01), None
patent: 2048669 (1980-12-01), None
patent: 6228010 (1994-08-01), None
patent: 90/03184 (1990-04-01), None
patent: 92/17587 (1992-10-01), None
patent: 96/33739 (1996-10-01), None
Shahin et al., “Characterization of the Protective Capacity and Immunogenicity of the 69-kD Outer Membrane Protein ofBordetella pertussis”, J. Exp. Med., 171:63-73, 1990.
Novotny et al., “Biologic and Protective Properties of the 69-kDa Outer Membrane Protein ofBordetella pertussis: A Novel Formation for an Acellular Pertussis Vaccine”, J. Infect. Dis., 164:114-122, 1991.
He et al., “Protective Role of Immunoglobulin G Antibodies to Filamentous Hemagglutinin and Pertactin ofBordetelle pertussisinBordetella parapertussisInfection”, Eur. J. Clin. Microbiol. Infect. Dis., 15(10):793-798, 1996.
Kobisch et al., “Identification of a 68-Kilodalton Outer Membrane Protein as the Major Protective Antigen ofBordetella bronchisepticaby Using Specific-Pathogen-Free Piglets”, Infect. Immun., 58(2):352-357, 1990.
Montaraz, et al., Identification of a 68-Kilodalton Protective Protein Antigen fromBordetella bronchiseptica, Infect. Immun., 47(3):744-751, 1985.
Mackintosh et al., “The use of a hardjo-pomona vaccine to prevent leptospiruria in cattle exposed to natural challenge withLeptospira interrogansserovar hardjo”, New Zealand Veterinary Journal, 28(9):174-177, 1980.
Bolin et al., “Effect of vaccination with a pentavalent leptospiral vaccine onLeptospira interrogansserovar hardjo type hardjo-bovis infection of pregnant cattle”, Am. J. Vet. Res., 50(1):161-165, 1989.
Novotny et al., “Evaluation ofBordetella bronchisepticaVaccines in Specific-Pathogen-Free Piglets with Bacterial Cell Surface Antigens in Enzyme-Linked Immunosorbent Assay”, Infect. Immun., 50(1):190-198, 1985.
Novotny et al., “Adenylate Cyclase Activity of a 68,000-Molecular-Weight Protein Isolated from the Outer Membrane ofBordetella bronchiseptica”, Infect. Immun., 50(1):199-206, 1985.
PCT International Search Report, PCT/IB2004/00146.
Dominowski Paul J.
Frantz Joseph C.
Krebs Richard L.
Shields Shelly L.
Sorensen Robert Greg
Gumbleton Timothy J.
Pfizer Inc.
Zeman Robert A
LandOfFree
Canine combination vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Canine combination vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Canine combination vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4200689